Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy

被引：0
|
作者：
Hazim, A. [1 ]
Xiao, A. [1 ]
Singh, A. [1 ]
Chung, K. [2 ]
dos Santos, P. A. Reck [2 ]
D'Cunha, J. [2 ]
Shanshal, M. [1 ]
Dimou, A. [1 ]
Parikh, K. [1 ]
Lou, Y. [3 ]
Manochakian, R. [3 ]
Leventakos, K. [1 ]
Molina, J. [1 ]
Mansfield, A. [1 ]
Ernani, V. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
chemoimmunotherapy; neoadjuvant; non small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07C.16
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [21] Clinical outcomes of conversion surgery following neoadjuvant chemoimmunotherapy in potentially resectable stage IIIA/IIIB non-small cell lung
    Yana Qi
    Yulan Sun
    Yanran Hu
    Hui Zhu
    Hongbo Guo
    Scientific Reports, 15 (1)
  • [22] Real-World Clinical Outcomes of Neoadjuvant Platinum-Based Chemotherapy with Nivolumab in Non-Small Cell Lung Cancer
    Shalata, Walid
    Daher, Sameh
    Rabinovitch, Natali Maimon
    Shamai, Sivan
    Kian, Waleed
    Turgeman, Ilit
    Dudnik, Yulia
    Kazareen, Olga
    Rovitsky, Yulia
    Sabo, Edmond
    Faber, Dan Levy
    Galili, Ronen
    Wiesel, Ory
    Baranovsky, Konstantin
    Agbarya, Abed
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [23] Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study
    Cheema, Parneet K.
    Syed, Iqra
    Gwadry-Sridhar, Femida
    Rakibuz-Zaman, Muhammad
    Sachdeva, Robin
    Pencz, Alec
    Zhan, Luna
    Hueniken, Katrina
    Patel, Devalben
    Balaratnam, Karmugi
    Khan, Khaleeq
    Grant, Benjamin
    Sheffield, Brandon S.
    Locke, M. Elizabeth O.
    Moldaver, Daniel
    Shanahan, Mary Kate
    Liu, Geoffrey
    Kuruvilla, M. Sara
    CURRENT ONCOLOGY, 2024, 31 (11) : 6735 - 6748
  • [24] Osimertinib as Neoadjuvant Therapy for Resectable EGFR Mutant Non-small Cell Lung Cancer: A Real-World Multicenter Retrospective Study
    Leng, X.
    Tang, J.
    Wang, S.
    Wang, Y.
    Li, P.
    Wang, S.
    Wei, X.
    Peng, L.
    Fang, Q.
    Han, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S979 - S979
  • [25] Three years follow-up of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
    Ji, Wenhao
    Jiang, Youhua
    Li, Yuetong
    Mao, Weimin
    Teng, Lisong
    NEOPLASMA, 2024, 71 (01) : 88 - 97
  • [26] Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer
    Chen, Tianxiang
    Cao, Zhengqi
    Sun, Yingjia
    Huang, Jia
    Shen, Shengping
    Jin, Yueping
    Jiang, Long
    Wen, Fengcai
    Zhao, Xiaochen
    Zhang, Ding
    Chen, Yanan
    Huang, Mengli
    Chen, Hao
    Lu, Shun
    Li, Ziming
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7549 - 7560
  • [27] Neoadjuvant Chemoimmunotherapy Increases Tumor Immune Lymphocytes Infiltration in Resectable Non-small Cell Lung Cancer
    Tianxiang Chen
    Zhengqi Cao
    Yingjia Sun
    Jia Huang
    Shengping Shen
    Yueping Jin
    Long Jiang
    Fengcai Wen
    Xiaochen Zhao
    Ding Zhang
    Yanan Chen
    Mengli Huang
    Hao Chen
    Shun Lu
    Ziming Li
    Annals of Surgical Oncology, 2023, 30 : 7549 - 7560
  • [28] Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy
    Xu, Fuhao
    Zhu, He
    Dong, Yinjun
    Li, Li
    Liu, Ning
    Yuan, Shuanghu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] Comparison of different criteria for estimating major pathological response in resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy
    Sun, Wei
    Liu, Xinying
    Wang, Chenglong
    Jiang, Yumeng
    Lin, Dongmei
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 69
  • [30] Evaluating the potential of immunotherapy and chemoimmunotherapy in the treatment of elderly non-small cell lung cancer patients: A real-world study
    Endo, Satoshi
    Honda, Takayuki
    Sato, Kazuaki
    Kubota, Natsushi
    Kamoshida, Tatsuhiko
    Mochizuki, Akifumi
    Fujii, Mayumi
    Ochi, Junichi
    Miyazaki, Yasunari
    Tsukada, Yoshikazu
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 37
12345